103 related articles for article (PubMed ID: 35810616)
1. Evaluation of markers of fibrinolysis and coagulation in pregnant women with human immunodeficiency virus.
Schapkaitz E; Libhaber E; Jacobson BF; Toman M; Gerber A; Büller HR
Thromb Res; 2022 Sep; 217():1-8. PubMed ID: 35810616
[TBL] [Abstract][Full Text] [Related]
2. Studies on blood coagulation-fibrinolysis system regarding kallikrein-kinin system in the utero-placental circulation during normal pregnancy, labor and puerperium.
Mutoh S; Kobayashi M; Hirata J; Itoh N; Maki M; Komatsu Y; Yoshida A; Sasa H; Kuroda K; Kikuchi Y
Agents Actions Suppl; 1992; 38 ( Pt 2)():320-9. PubMed ID: 1462839
[TBL] [Abstract][Full Text] [Related]
3. Coagulation and fibrinolytic parameters in normal pregnancy and in pregnancy complicated by intrauterine growth retardation.
Bellart J; Gilabert R; Fontcuberta J; Carreras E; Miralles RM; Cabero L
Am J Perinatol; 1998 Feb; 15(2):81-5. PubMed ID: 9514130
[TBL] [Abstract][Full Text] [Related]
4. Changes of new coagulation markers in healthy pregnant women and establishment of reference intervals in Changsha.
Yang Y; Hu Y; Wu M; Xiang Z
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Apr; 47(4):469-478. PubMed ID: 35545342
[TBL] [Abstract][Full Text] [Related]
5. von Willebrand factor propeptide-to-antigen ratio in HIV-infected pregnancy: Evidence of endothelial activation.
Schapkaitz E; Libhaber E; Jacobson BF; Meiring M; Büller HR
J Thromb Haemost; 2021 Dec; 19(12):3168-3176. PubMed ID: 34409729
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of undetectable and suppressed viral load in HIV-infected pregnant women initiating Option B+ in Uganda: an observational study nested within a randomized controlled trial.
Gabagaya G; Rukundo G; Amone A; Wavamunno P; Namale-Matovu J; Lubega I; Nakabiito C; Namukwaya Z; Nolan M; Malamba SS; King R; Homsy J; Fowler MG; Musoke P
BMC Infect Dis; 2021 Sep; 21(1):907. PubMed ID: 34481464
[TBL] [Abstract][Full Text] [Related]
7. Studies on oral contraceptive-induced changes in blood coagulation and fibrinolysis and the estrogen effect on endothelial cells.
Quehenberger P; Kapiotis S; Pärtan C; Schneider B; Wenzel R; Gaiger A; Speiser W
Ann Hematol; 1993 Jul; 67(1):33-6. PubMed ID: 8392873
[TBL] [Abstract][Full Text] [Related]
8. Plasminogen activator inhibitor-2 and impaired fibrinolysis in pregnancy and sickle cell anemia.
Shome D; Al-Jamea L; Woodman A; Salem AH; Bakhiet M; Taha S; Sandhu AK; Al-Yami FS; Waheed KB; Elnagi EA; Almish M; Quiambao JV
Arch Gynecol Obstet; 2024 Jun; 309(6):2447-2458. PubMed ID: 37401942
[TBL] [Abstract][Full Text] [Related]
9. Studies of blood coagulation-fibrinolysis regarding kallikrein-kinin system in severe preeclampsia.
Mutoh S; Kobayashi M; Hirata J; Itoh N; Maki M; Komatsu Y; Yoshida A; Sasa H; Kuroda K; Kikuchi Y
Agents Actions Suppl; 1992; 38 ( Pt 2)():342-9. PubMed ID: 1462840
[TBL] [Abstract][Full Text] [Related]
10. Markers of intravascular coagulation and fibrinolysis in preeclampsia: association with intrauterine growth retardation.
Schjetlein R; Haugen G; Wisløff F
Acta Obstet Gynecol Scand; 1997 Jul; 76(6):541-6. PubMed ID: 9246959
[TBL] [Abstract][Full Text] [Related]
11. Plasma viraemia in HIV-positive pregnant women entering antenatal care in South Africa.
Myer L; Phillips TK; Hsiao NY; Zerbe A; Petro G; Bekker LG; McIntyre JA; Abrams EJ
J Int AIDS Soc; 2015; 18(1):20045. PubMed ID: 26154734
[TBL] [Abstract][Full Text] [Related]
12. Plasma levels of fibrinolytic and coagulation biomarkers in HIV-infected individuals on highly active antiretroviral therapy: A case-control study in a Northern Ghanaian population.
Derigubah CA; Nkansah C; Mensah K; Appiah SK; Osei-Boakye F; Odame E; Owusu M; Serwaa D; Hubert MA; Bani SB; Kuugbee E; Issahaku RG; Debrah AY; Addai-Mensah O
Health Sci Rep; 2023 Jul; 6(7):e1436. PubMed ID: 37484058
[TBL] [Abstract][Full Text] [Related]
13. Coagulation and fibrinolysis parameters in normal pregnancy and in gestational diabetes.
Bellart J; Gilabert R; Fontcuberta J; Carreras E; Miralles RM; Cabero L
Am J Perinatol; 1998 Aug; 15(8):479-86. PubMed ID: 9788646
[TBL] [Abstract][Full Text] [Related]
14. Time to viral load suppression in antiretroviral-naive and -experienced HIV-infected pregnant women on highly active antiretroviral therapy: implications for pregnant women presenting late in gestation.
Aziz N; Sokoloff A; Kornak J; Leva NV; Mendiola ML; Levison J; Feakins C; Shannon M; Cohan D
BJOG; 2013 Nov; 120(12):1534-47. PubMed ID: 23924192
[TBL] [Abstract][Full Text] [Related]
15. Coagulation imbalance and neurocognitive functioning in older HIV-positive adults on suppressive antiretroviral therapy.
Montoya JL; Iudicello J; Oppenheim HA; Fazeli PL; Potter M; Ma Q; Mills PJ; Ellis RJ; Grant I; Letendre SL; Moore DJ;
AIDS; 2017 Mar; 31(6):787-795. PubMed ID: 28099190
[TBL] [Abstract][Full Text] [Related]
16. Frequency of Viremic Episodes in HIV-Infected Women Initiating Antiretroviral Therapy During Pregnancy: A Cohort Study.
Myer L; Dunning L; Lesosky M; Hsiao NY; Phillips T; Petro G; Zerbe A; McIntyre JA; Abrams EJ
Clin Infect Dis; 2017 Feb; 64(4):422-427. PubMed ID: 27927852
[TBL] [Abstract][Full Text] [Related]
17. [Studies on coagulation-fibrinolysis during normal pregnancy, labor and puerperium using recently developed molecular markers].
Komatsu Y
Nihon Sanka Fujinka Gakkai Zasshi; 1995 Jul; 47(7):627-34. PubMed ID: 7636333
[TBL] [Abstract][Full Text] [Related]
18. [Hypercoagulability during pregnancy: evidences for a thrombophilic state].
Maiello M; Torella M; Caserta L; Caserta R; Sessa M; Tagliaferri A; Bernacchi M; Napolitano M; Nappo C; De Lucia D; Panariello S
Minerva Ginecol; 2006 Oct; 58(5):417-22. PubMed ID: 17006429
[TBL] [Abstract][Full Text] [Related]
19. Coagulation and fibrinolysis variables in pregnant women with type 1 diabetes mellitus.
Bronisz A; Rosc D; Bronisz M; Szymanski W; Junik R
Med Sci Monit; 2008 Nov; 14(11):CR574-9. PubMed ID: 18971874
[TBL] [Abstract][Full Text] [Related]
20. Progress towards the UNAIDS 95-95-95 targets among pregnant women in South Africa: Results from the 2017 and 2019 national Antenatal HIV Sentinel Surveys.
Woldesenbet S; Cheyip M; Lombard C; Manda S; Ayalew K; Kufa T; Puren A
PLoS One; 2022; 17(7):e0271564. PubMed ID: 35862306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
